“Efficacy and safety of bulevirtide in patients with chronic hepatitis D treated under early access in Switzerland: a retrospective analysis”, Swiss Med Wkly, vol. 156, no. 2, p. 4736, Feb. 2026, doi: 10.57187/4736.